ATC codes:
L01DB02
EMLc
Indication
Acute myeloid leukaemia with recurrent genetic abnormalities
ICD11 code:
2B30.0
INN
Daunorubicin
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
50 mg in vial (as hydrochloride) powder for injection ;
20 mg in vial (as hydrochloride) powder for injection ;
2 mg per mL in vial (as hydrochloride) ;
5 mg per mL in vial (as hydrochloride)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the addition of additional formulations of daunorubicin (injection 2 mg/mL and 5 mg/mL in vial and powder for injection 20 mg in vial) to the EML and EMLc.